https://news.augustaheadlines.com/story/533566/colorectal-cancer-pipeline-outlook-2025-clinical-trials-medication-therapies-companies-by-delveinsight.html 2025-09-01T14:36:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/533565/hemophilia-b-market-outlook-2034-clinical-trials-market-size-medication-prevalence-companies-by-delveinsight.html 2025-09-01T14:34:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/533564/5ht2-agonist-pipeline-shows-strong-growth-20-companies-advancing-clinical-development-delveinsight.html 2025-09-01T14:32:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/533563/embolic-protection-devices-market-is-expected-to-sour-at-a-cagr-of-758-by-2032-delveinsight.html 2025-09-01T14:30:05+00:00 daily 1.0 https://news.augustaheadlines.com/story/533562/oncolytic-virus-cancer-therapy-pipeline-outlook-2025-clinical-trial-studies-ema-pdma-fda-approvals-moa-roa-nda-ind-and-companies.html 2025-09-01T14:28:32+00:00 daily 1.0 https://news.augustaheadlines.com/story/533561/tgfb-inhibitor-pipeline-outlook-2025-clinical-trial-studies-ema-pdma-fda-approvals-moa-roa-nda-ind-and-companies.html 2025-09-01T14:26:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/533560/pancreatic-cancer-pipeline-insights-report-2025-clinical-trial-studies-ema-pdma-fda-approvals-moa-roa-nda-ind-and-companies.html 2025-09-01T14:24:16+00:00 daily 1.0 https://news.augustaheadlines.com/story/533559/pancreatic-cancer-pipeline-outlook-2025-clinical-trial-studies-ema-pdma-fda-approvals-moa-roa-nda-ind-and-companies.html 2025-09-01T14:22:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/533558/checkpoint-inhibitors-competitive-landscape-pipeline-2025-emerging-therapies-leading-companies-and-future-outlook.html 2025-09-01T14:20:04+00:00 daily 1.0 https://news.augustaheadlines.com/story/533557/ibn-technologies-payroll-outsourcing-services-assist-us-companies-optimize-operations.html 2025-09-01T14:18:02+00:00 daily 1.0